You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

15-096

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parkinson Disease Trial in Turku (HER-096, Placebo)

Recruiting
  • Parkinson Disease
  • Turku, Finland
    Clinical Research Services Turku - CRST Oy
Jun 13, 2023

Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)

Recruiting
  • Recurrent Osteosarcoma
  • humanized anti-GD2 antibody
  • GM-CSF
  • Los Angeles, California
  • +2 more
Dec 22, 2022

Hepatopulmonary Syndrome (HPS) Trial in Beijing (Proteomic sequencing)

Recruiting
  • Hepatopulmonary Syndrome (HPS)
  • Proteomic sequencing
  • Beijing, China
    No.8, Xitoutiao, Youan Men Wai, Fengtai District
Jul 3, 2023

HIV Trial (Health Equity, Social Media Influencers, Intersectional Stigma Reduction)

Recruiting
  • HIV Infections
  • Health Equity
  • +4 more
  • Durham, North Carolina
    FHI 360
Aug 25, 2022

Tumors Trial in Hong Kong (Ovarian tissue freezing and subsequent auto-transplantation after thawing)

Not yet recruiting
  • Neoplasms
  • Ovarian tissue freezing and subsequent auto-transplantation after thawing
  • Hong Kong, Hong Kong
    Prince of Wales Hospital
Apr 14, 2023

Anterior Cruciate Ligament Reconstruction, Bone-Patellar Tendon-Bone Grafting Trial in Sittard (Blood flow restriction training,

Not yet recruiting
  • Anterior Cruciate Ligament Reconstruction
  • Bone-Patellar Tendon-Bone Grafting
  • Blood flow restriction training
  • Resistance training
  • Sittard, Limburg, Netherlands
    Zuyderland Medical Center
Jul 25, 2023

Hydration of Scars Trial in Ghent (Application of Aruba Aloë formula F-BC-096 or control)

Withdrawn
  • Hydration of Scars
  • Application of Aruba Aloë formula F-BC-096 or control
  • Ghent, Belgium
    University Hospital Ghent
Jul 1, 2021

Skin Kaposi Sarcoma Trial in United States (other, behavioral, biological)

Recruiting
  • Skin Kaposi Sarcoma
  • Laboratory Biomarker Analysis
  • +3 more
  • La Jolla, California
  • +9 more
Jun 22, 2022

Quality of Life of Elderly People With Depressive Symptoms

Not yet recruiting
  • Depression
    • (no location specified)
    May 2, 2023

    Nutritional Status of Adult Slovenes After the Covid-19 Epidemic

    Enrolling by invitation
    • Body Weight
    • +2 more
    • No intervention
    • Ljubljana, Slovenia
      Faculty of sport
    Jul 2, 2022

    Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Head and Neck Squamous Cell Carcinoma
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 25, 2023

    Schizophrenia Trial in Worldwide (Placebo, AVP-786)

    Recruiting
    • Schizophrenia
    • Little Rock, Arkansas
    • +81 more
    Aug 23, 2022

    Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

    Recruiting
    • Non-Cystic Fibrosis Bronchiectasis
    • Brensocatib 10 mg
    • +2 more
    • Birmingham, Alabama
    • +416 more
    Jan 24, 2023

    Colorectal Cancer, Clostridioides Difficile Infection, Diarrhea Trial in Koscierzyna (Sanprobi IBS®)

    Recruiting
    • Colorectal Cancer
    • +2 more
    • Sanprobi IBS®
    • Kościerzyna, Poland
      Unit of Surgery with Unit of Oncological Surgery in Koscierzyna
    Aug 24, 2023

    Clostridium Difficile Infection Trial in United States (Ibezapolstat, Vancomycin)

    Recruiting
    • Clostridium Difficile Infection
    • Scottsdale, Arizona
    • +28 more
    Jan 31, 2023

    COVID-19 Trial in Worldwide (Baricitinib, Dexamethasone, Placebo)

    Completed
    Has Results
    • COVID-19
    • Birmingham, Alabama
    • +71 more
    Jun 22, 2022

    Antiphospholipid Syndrome, Ischemic Stroke, Transient Ischemic Attack Trial in Korea, Republic of (Antiplatelet Drug, Warfarin)

    Not yet recruiting
    • Antiphospholipid Syndrome
    • +5 more
    • Anyang, Korea, Republic of
    • +34 more
    Aug 15, 2023

    Craniofacial Architecture in Young, Non-overweight Apneic Adult

    Completed
    • OSA
    • CBCT
    • Liège, Belgium
      CHU Liège, site Brull
    Aug 31, 2023

    Hypoglycaemia (Low Blood Sugar) in Diabetes and Adrenal Failure

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • +2 more
    • Continuous Glucose Monitoring
    • London, United Kingdom
      Charing Cross Hospital, Imperial College Healthcare NHS Trust
    Apr 13, 2023

    Type 2 Diabetes Trial in Worldwide (Tirzepatide, Placebo)

    Completed
    Has Results
    • Type 2 Diabetes Mellitus
    • Huntington Park, California
    • +52 more
    Oct 18, 2021

    Myeloma Trial in Houston (Fludarabine phosphate, Cyclophosphamide, NY-ESO-1 TCR/IL-15 NK)

    Not yet recruiting
    • Myeloma
    • Fludarabine phosphate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2023

    Human Immunodeficiency Virus Prevention, Human Immunodeficiency Virus (HIV) Trial run by the NIAID (VRC-HIVRGP096-00-VP, Alum

    Completed
    Has Results
    • Human Immunodeficiency Virus Prevention
    • Human Immunodeficiency Virus (HIV)
    • VRC-HIVRGP096-00-VP
    • Alum Adjuvant
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 6, 2021

    Lateral Epicondylitis, Tennis Elbow, Tendonitis Elbow Trial in Istanbul (Blood flow restriction, Multimodal rehabilitation)

    Recruiting
    • Lateral Epicondylitis
    • +2 more
    • Blood flow restriction
    • Multimodal rehabilitation
    • Istanbul, Büyükçekmece, Turkey
      Istanbul University - Cerrahpasa
    Aug 18, 2023

    Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

    Not yet recruiting
    • Multiple Myeloma
    • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
    • +3 more
    • (no location specified)
    Jul 28, 2023

    Recurrent Ovarian Cancer, Recurrent Fallopian Tube Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Worldwide

    Active, not recruiting
    • Recurrent Ovarian Cancer
    • +2 more
    • Relacorilant, 100mg QD
    • +3 more
    • Birmingham, Alabama
    • +20 more
    Jun 27, 2022